ATE346865T1 - Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp - Google Patents

Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp

Info

Publication number
ATE346865T1
ATE346865T1 AT99966605T AT99966605T ATE346865T1 AT E346865 T1 ATE346865 T1 AT E346865T1 AT 99966605 T AT99966605 T AT 99966605T AT 99966605 T AT99966605 T AT 99966605T AT E346865 T1 ATE346865 T1 AT E346865T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
cell type
present
specific cell
antigens
Prior art date
Application number
AT99966605T
Other languages
English (en)
Inventor
Jennie P Mather
Laura N Bald
Penelope R Roberts
Jean-Philippe F Stephan
Original Assignee
Raven Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raven Biotechnologies Inc filed Critical Raven Biotechnologies Inc
Application granted granted Critical
Publication of ATE346865T1 publication Critical patent/ATE346865T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99966605T 1998-12-22 1999-12-22 Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp ATE346865T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21853998A 1998-12-22 1998-12-22

Publications (1)

Publication Number Publication Date
ATE346865T1 true ATE346865T1 (de) 2006-12-15

Family

ID=22815514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99966605T ATE346865T1 (de) 1998-12-22 1999-12-22 Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp

Country Status (11)

Country Link
US (1) US20040146990A1 (de)
EP (1) EP1141026B1 (de)
JP (2) JP2002538772A (de)
CN (1) CN1258539C (de)
AT (1) ATE346865T1 (de)
AU (1) AU776675B2 (de)
CA (1) CA2352471A1 (de)
DE (1) DE69934250T2 (de)
DK (1) DK1141026T3 (de)
HK (1) HK1041273B (de)
WO (1) WO2000037503A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR177400A0 (en) * 2000-11-29 2000-12-21 Cancerprobe Pty Ltd Probes for identifying cancer-specific antigens
CA2475356A1 (en) 2002-02-12 2003-08-21 Raven Biotechnologies, Inc. Human fetal bladder-derived epithelial cells
KR101363252B1 (ko) 2005-02-04 2014-02-13 레이븐 바이오테크놀로지스, 인코퍼레이티드 Ｅｐｈａ2에 결합하는 항체 및 그것의 사용방법
JPWO2006109533A1 (ja) * 2005-03-31 2008-10-23 国立大学法人大阪大学 細胞膜表面抗原エピトープに対する抗体の作製法及びアッセイ法
KR20080097183A (ko) * 2005-12-16 2008-11-04 래리 마크 웨이센탈 내피 세포를 함유하는 미소응집체
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
WO2013040142A2 (en) 2011-09-16 2013-03-21 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
WO2011119484A1 (en) 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
DE102010039018B4 (de) * 2010-08-06 2013-02-28 Technische Universität Dresden Anti-La Antikörper und ihre Anwendung zum Immunotargeting
US9915592B2 (en) * 2013-03-06 2018-03-13 General Electric Company Methods of analyzing an H and E stained biological sample
JP6168580B1 (ja) * 2016-02-24 2017-07-26 積水メディカル株式会社 イムノクロマトグラフィーを利用した癌胎児性フィブロネクチンの検出方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487829A (en) * 1982-03-23 1984-12-11 Massachusetts Institute Of Technology Production and use of monoclonal antibodies against adenoviruses
US5364785A (en) * 1990-02-09 1994-11-15 Genentech, Inc. Method of isolating lung cell line
EP0673389A1 (de) * 1992-11-19 1995-09-27 Dana Farber Cancer Institute Antikörper gegen den gm-csf rezeptor und dessen verwendung
US5714385A (en) * 1995-05-10 1998-02-03 Genentech, Inc. Media for culturing schwann cells
US5721139A (en) * 1995-05-10 1998-02-24 Genentech, Inc. Isolating and culturing schwann cells
IL122233A (en) * 1996-12-06 2001-04-30 Akzo Nobel Nv Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them
US6004528A (en) * 1997-09-18 1999-12-21 Bergstein; Ivan Methods of cancer diagnosis and therapy targeted against the cancer stemline

Also Published As

Publication number Publication date
CN1350549A (zh) 2002-05-22
EP1141026A1 (de) 2001-10-10
AU2211300A (en) 2000-07-12
EP1141026B1 (de) 2006-11-29
CA2352471A1 (en) 2000-06-29
DK1141026T3 (da) 2007-03-26
WO2000037503A1 (en) 2000-06-29
JP2009001562A (ja) 2009-01-08
JP2002538772A (ja) 2002-11-19
DE69934250D1 (de) 2007-01-11
JP4426627B2 (ja) 2010-03-03
US20040146990A1 (en) 2004-07-29
AU776675B2 (en) 2004-09-16
CN1258539C (zh) 2006-06-07
DE69934250T2 (de) 2007-05-24
HK1041273A1 (en) 2002-07-05
HK1041273B (en) 2007-05-18

Similar Documents

Publication Publication Date Title
DK1414858T3 (da) Kamelid-enkeltkæde-VHH-antistoffer, fremgangsmåde til fremstilling heraf i et pattedyr samt anvendelser heraf
ATE439380T1 (de) Methoden zur herstellung humaner monoklonaler antikörper
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
ATE488576T1 (de) Schnellproduktion monoklonaler antikörper
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
ES2171705T3 (es) Complejos de polipeptido-dendrimero.
DE69434578D1 (de) Expressionsvektoren die für bispezifische Proteine kodieren, und Verfahren zur Herstellung von biologisch-aktiven bispezifischen Fusionsproteine in Zellen von Säugertieren
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
DE69521794D1 (de) Zellen mit mehreren geänderten epitopen auf einem oberflächeantigen zur verwendung in transplantation
DE69934250D1 (de) Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp
ATE468390T1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
ATE227579T1 (de) Verfahren zur herstellung von makrophagen und ausrüstungen zur durchführung dieses verfahrens
ZA912036B (en) Catalytic antibody components
ATE279443T1 (de) A3c6e2, ein monoklonaler antikörper spezifisch für den humanen stammzellfaktor (scf)-rezeptor
PT1200561E (pt) Clone celular recombinante estavel, sua producao e utilizacao
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
GR3031607T3 (en) Selective system scan for multizone radiotelephone subscriber units.
IL122233A0 (en) Monoclonal antibodies their production and pharmaceutical compositions and diagnostic reagents containing them
DK1711531T3 (da) Neutraliserende anti-TLR4/-MD-2-antistoffer og fremgangsmåder til anvendelse deraf
CA2480717A1 (en) Method for producing monoclonal antibodies
AU2003283240A8 (en) Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells
ZA9710964B (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
ATA168387A (de) Verfahren zur herstellung von zellinien, die monoklonale antikörper produzieren
DE69505365D1 (de) Immunologisches verfahren zum nachweis von glykosaminoglykan-aktiviertem antithrombin iii; die entsprechenden monoklonalen antikörper und deren herstellung
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties